Bacterial &bgr;-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) as a Target for Novel Antibacterial Agents Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|5|651-667

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.5, 2015-02, pp. : 651-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bacterial #946;-Ketoacyl-Acyl Carrier Protein Synthase III (FabH): An Attractive Target for the Design of New Broad-Spectrum Antimicrobial Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 1, 2008-01 ,pp. : 36-45

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Research of &bgr;-Ketoacyl-ACP Synthase III (FabH) Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1225-1237

Bentham Science Publishers

Access to resources Recommend Favorite

Novel FabH inhibitors: a patent and article literature review (2000 – 2012)

By Luo Yin   Yang Yu-Shun   Fu Jie   Zhu Hai-Liang  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1325-1336

Informa Healthcare

Access to resources Recommend Favorite

Identification of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein Reductase

By  

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 3, 2005-09 ,pp. : 297-305

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of Novel &bgr;-Carboline Derivatives as Antiproliferative Agents

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 9, 2013-11 ,pp. : 879-885

Bentham Science Publishers

Access to resources Recommend Favorite